82266-85-1 Usage
Description
(6aR,7R,9aR)-11-((3S,5R)-3,5-dihydroxy-2-Methylcyclohex-1-en-1-yl)-6a-Methyl-7-((R)-6-Methylheptan-2-yl)-2-phenyl-4a,5,6,6a,7,8,9,9a-octahydrocyclopenta[f][1,2,4]triazolo[1,2-a]cinnoline-1,3(2H,11H)-dione is a complex organic compound characterized by its unique molecular structure. It features a cyclopentane ring fused to a triazolocinnoline ring system, with various functional groups including a cyclohexene, a dihydroxy group, a methyl group, and a heptan-2-yl substituent. (6aR,7R,9aR)-11-((3S,5R)-3,5-dihydroxy-2-Methylcyclohex-1-en-1-yl)-6a-Methyl-7-((R)-6-Methylheptan-2-yl)-2-phenyl-4a,5,6,6a,7,8,9,9a-octahydrocyclopenta[f][1,2,4]triazolo[1,2-a]cinnoline-1,3(2H,11H)-dione holds potential pharmaceutical or biological activities, with its specific properties likely influenced by its stereochemistry, molecular interactions, and conformational characteristics.
Description
Gallotannin, also known as Tannic acid, is a primary gallo-tannin derived from hydrolyzable tannins found in gall nuts and various plant sources. It possesses weak acidic properties and a strong astringent taste. Its hydroxy and carboxy groups enable interactions with biopolymers and macromolecules, making it a promising pharmaceutical candidate for various applications.
Uses
Since the provided materials do not specify any particular uses for (6aR,7R,9aR)-11-((3S,5R)-3,5-dihydroxy-2-Methylcyclohex-1-en-1-yl)-6a-Methyl-7-((R)-6-Methylheptan-2-yl)-2-phenyl-4a,5,6,6a,7,8,9,9a-octahydrocyclopenta[f][1,2,4]triazolo[1,2-a]cinnoline-1,3(2H,11H)-dione, we can only speculate on possible applications based on its structural features and potential pharmaceutical or biological activities. However, without specific information on its uses, we cannot list any applications for this compound.
For comparison, here is the example provided for Gallotannin:
Uses
Used in Anticancer Applications:
Gallotannin is employed as an anticancer agent, particularly against solid malignancies such as liver, breast, lung, pancreatic, colorectal, and ovarian cancers. It modulates several oncological signaling pathways, including JAK/STAT, RAS/RAF/mTOR, TGF-β1/TGF-β1R, VEGF/VEGFR, and CXCL12/CXCR4 axes, exerting inhibitory effects on tumor growth and progression. Additionally, it demonstrates synergistic anticancer effects when combined with conventional chemotherapeutic drugs, enhancing chemo-sensitivity and efficacy in resistant cases.
Used in Drug Delivery Systems:
To overcome the limitations of gallotannin, novel drug delivery systems have been developed to enhance its applications and efficacy against cancer cells. Various organic and metallic nanoparticles have been employed as carriers for gallotannin delivery, aiming to improve its delivery, bioavailability, and therapeutic outcomes.
Check Digit Verification of cas no
The CAS Registry Mumber 82266-85-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,2,6 and 6 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 82266-85:
(7*8)+(6*2)+(5*2)+(4*6)+(3*6)+(2*8)+(1*5)=141
141 % 10 = 1
So 82266-85-1 is a valid CAS Registry Number.
82266-85-1Relevant articles and documents
An Improved Synthesis of 1α-hydroxy Vitamin D3
Nerinckx, W.,Clercq, P. J. De,Couwenhoven, C.,Overbeek, W. R. M.,Halkes, S. J.
, p. 9419 - 9430 (2007/10/02)
The efficient and stereoselective introduction of the 1α-OH function in vitamin D3 is described starting from the known previtamin D3 adduct 6.The sequence involves the stereoselective allylic bromination to 9, followed by substituti
